22 - Beyond the 101: Pondering Perplexing Prescribing Issues

Thursday, October 17, 2024

10:30 AM – 11:45 AM US PT

Location: 408 B

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Pranita Tamma, MD, MHS

Associate Professor
Johns Hopkins School of Medicine
Baltimore, MD, United States
Erin McCreary, PharmD (she/her/hers)

Director of Infectious Diseases Improvement and Clinical Research Innovation
University of Pittsburgh Medical Center
Pittsburgh, PA, United States

Faculty(s)

Lisa Davidson, MD (she/her/hers)

Medical Director, Antimicrobial Support Network
Antimicrobial Support Network
Atrium Health
Charlotte, North Carolina, United States
Alison Tribble, MD, MSCE

Associate Professor of Pediatrics, Division of Pediatric Infectious Diseases
C.S. Mott Children's Hospital, University of Michigan Health
Ann Arbor, MI, United States
David Ha, PharmD, BCIDP

Infectious Diseases and Antimicrobial Stewardship Pharmacist
Stanford Health Care
Stanford, CA, United States

Disclosure(s):

Pranita Tamma, MD, MHS: No financial relationships to disclose

Erin K. McCreary, PharmD: Abbvie: Advisor/Consultant; Basilea: Advisor/Consultant; Ciadara: Advisor/Consultant; Entasis: Advisor/Consultant; Ferring: Advisor/Consultant; GSK: Advisor/Consultant, Honoraria; Melinta: Advisor/Consultant; Merck: Advisor/Consultant; Pfizer: Honoraria; Shionogi: Advisor/Consultant, Honoraria

Lisa Davidson, MD: No financial relationships to disclose

Alison C. Tribble, MD, MSCE: No financial relationships to disclose

David R. Ha, PharmD, BCIDP: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

indicate if three days of antibiotics are sufficient for community-acquired pneumonia;
identify effective management of group a streptococcus infections;
analyze whether daptomycin can be co-administered with statins.

Presentations:

10:30 AM – 10:55 AM US PT

Three days of antibiotics for uncomplicated community-acquired pneumonia: Ready for prime time?
Speaker: Lisa Davidson, MD (she/her/hers) – Atrium Health
10:55 AM – 11:20 AM US PT

Do we still need to treat group A streptococcal pharyngitis for 10 days?
Speaker: Alison C. Tribble, MD, MSCE – C.S. Mott Children's Hospital, University of Michigan Health
11:20 AM – 11:45 AM US PT

Daptomycin and statins: To hold or not to hold
Speaker: David R. Ha, PharmD, BCIDP – Stanford Health Care